244
Views
20
CrossRef citations to date
0
Altmetric
Technical Notes

Calcium-oligochitosan-pectin microcarrier for colonic drug delivery

, , , , , , , , & show all
Pages 260-265 | Received 07 Apr 2019, Accepted 06 Nov 2019, Published online: 25 Nov 2019

References

  • Ahsan SM, Thomas M, Reddy KK, Sooraparaju SG, Asthana A, Bhatnagar I. 2018. Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol. 110:97–109.
  • Akala EO, Elekwachi O, Chase V, Johnson H, Lazarre M, Scott K. 2003. Organic redox-initiated polymerization process for the fabrication of hydrogels for colon-specific drug delivery. Drug Dev Ind Pharm. 29(4):375–386.
  • Amiji M, Tailor R, Ly M-K, Goreham J. 1997. Gelatin-poly(ethylene oxide) semi-interpenetrating polymer network with pH-sensitive swelling and enzyme-degradable properties for oral drug delivery. Drug Dev Ind Pharm. 23(6):575–582.
  • Bakravi A, Ahamadian Y, Hashemi H, Namazi H. 2018. Synthesis of gelatin-based biodegradable hydrogel nanocomposite and their application as drug delivery agent. Adv Polym Technol. 37(7):2625–2635.
  • Bourgeois S, Gernet M, Pradeau D, Andremont A, Fattal E. 2006. Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads. Int J Pharm. 324(1):2–9.
  • Butte K, Momin M, Deshmukh H. 2014. Optimisation and in vivo evaluation of pectin based drug delivery system containing curcumin for colon. Int J Biomater. 2014:1.
  • Chaurasia M, Chourasia MK, Jain NK, Jain A, Soni V, Gupta Y, Jain SK. 2008. Methotrexate bearing calcium pectinate microspheres: a platform to achieve colon-specific drug release. CDD. 5(3):215–219.
  • Chen K, Zhang H. 2019. Alginate/pectin aerogel microspheres for controlled release of proanthocyanidins. Int J Biol Macromol. 136:936–943.
  • Crouse JZ, Mahuta KM, Mikulski BA, Harvestine JN, Guo X, Lee JC, Kaltchev MG, Midelfort KS, Tritt CS, Chen J, et al. 2015. Development of a microscale red blood cell-shaped pectin-oligochitosan hydrogel system using an electrospray-vibration method: preparation and characterization. JABFM. 13(4):e326–e331.
  • Cummings JH, Macfarlane GT. 1991. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 70(6):443–459.
  • Dupuis G, Chambin O, Génelot C, Champion D, Pourcelot Y. 2006. Colonic drug delivery: influence of cross-linking agent on pectin beads properties and role of the shell capsule type. Drug Dev Ind Pharm. 32(7):847–855.
  • Gawkowska D, Cybulska J, Zdunek A. 2018. Cross-linking of sodium carbonate-soluble pectins from apple by zinc ions. Carbohydr Polym. 196:1–7.
  • Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. 1973. Biological interactions between polysaccharides and divalent cations: the egg-box model. FEBS Lett. 32(1):195–198.
  • Gunter EA, Popeyko OV, Markov PA, Martinson EA, Litvinets SG, Durnev EA, Popov SV, Ovodov YS. 2014. Swelling and morphology of calcium pectinate gel beads obtained from Silene vulgaris callus modified pectins. Carbohydr Polym. 103:550–557.
  • Harvestine JNM, Mikulski, BA, Mahuta KM, Crouse JZ, Guo X, Lee JC, Midelfort KS, Chen J, Zhang W. 2014. A novel red-blood-cell-shaped pectin-oligochitosan hydrogel system. Part Part Syst Charact. 31(9):955–959.
  • Isolauri E, Salminen S, Ouwehand AC. 2004. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 18(2):299–313.
  • Jawad N, Direkze N, Leedham SJ. 2011. Inflammatory bowel disease and colon cancer. Recent Results Cancer Res. 185:99–115.
  • Jiang L, Li X, Liu L, Zhang Q. 2013. Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles. Int J Nanomed. 8:1825–1834.
  • Kim MS, Yeom DW, Kim SR, Yoon HY, Kim CH, Son HY, Kim JH, Lee S, Choi YW. 2016. Development of a chitosan based double layer-coated tablet as a platform for colon-specific drug delivery. DDDT. 11:45–57.
  • Kosaraju SL. 2005. Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery. Crit Rev Food Sci Nutr. 45(4):251–258.
  • Maroni A, Zema L, Del Curto MD, Foppoli A, Gazzaniga A. 2012. Oral colon delivery of insulin with the aid of functional adjuvants. Adv Drug Deliv Rev. 64(6):540–556.
  • Marques MRC, Loebenberg R, Almukainzi M. 2011. Simulated biological fluids with possible application in dissolution testing. Dissolution Technol. 18(3):15–28.
  • McConnell EL, Basit AW. 2008. Targeting the colon using COLAL: a novel bacteria-sensitive drug delivery system. In: Rathbone MJ, Roberts MS, editors. Modified release drug delivery technology. New York and London: Informa healthcare.
  • Moffat JN, Timothy R, Parker R, Wellner N, Ring SG. 2007. The environmental response and stability of pectin and poly-L-lysine multilayers. Carbohydr Polym. 70(4):422–429.
  • Morris ER, Powell DA, Gidley MJ, Rees DA. 1982. Conformations and interactions of pectins. I. Polymorphism between gel and solid states of calcium polygalacturonate. J Mol Biol. 155(4):507–516.
  • Odeku OA, Fell JT. 2005. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon. J Pharm Pharmacol. 57(2):163–168.
  • Perera G, Barthelmes J, Bernkop-Schnurch A. 2010. Novel pectin-4-aminothiophenole conjugate microparticles for colon-specific drug delivery. J Control Rel. 145(3):240–246.
  • Philip AK, Dabas S, Pathak K. 2009. Optimized prodrug approach: a means for achieving enhanced anti-inflammatory potential in experimentally induced colitis. J Drug Target. 17(3):235–241.
  • Philip AK, Philip B. 2010. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 25(2):79–87.
  • Ramasamy T, Ruttala HB, Shanmugam S, Umadevi SK. 2013. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis. Drug Deliv. 20(2):65–77.
  • Ravi V, Siddaramaiah P, Kumar TM. 2008. Influence of natural polymer coating on novel colon targeting drug delivery system. J Mater Sci Mater Med. 19(5):2131–2136.
  • Rubinstein A. 1995. Approaches and opportunities in colon-specific drug delivery. Crit Rev Ther Drug Carrier Syst. 12(2–3):101–149.
  • Selivanov NY, Sorokina IV, Selivanova OG, Sokolov OI, Ignatov VV. 2008. Investigation of enzymatic degradation of pectin polysaccharides under limiting conditions. Biochem Moscow. 73(1):80–86.
  • Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA A Cancer J Clin. 69(1):7–34.
  • Voragen F. 2003. Advances in pectin and pectinase research. 1st ed. Dordrecht (Netherlands): Springer.
  • Xi MM, Zhang SQ, Wang XY, Fang KQ, Gu Y. 2005. Study on the characteristics of pectin-ketoprofen for colon targeting in rats. Int J Pharm. 298(1):91–97.
  • Yang L, Chu JS, Fix JA. 2002. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 235(1–2):1–15.
  • Zhang W, Mahuta KM, Mikulski BA, Harvestine JN, Crouse JZ, Lee JC, Kaltchev MG, Tritt CS. 2016. Novel pectin-based carriers for colonic drug delivery. Pharm Dev Technol. 21(1):127–130.
  • Zhang W, Zhao S, Rao W, Snyder J, Choi JK, Wang J, Khan IA, Saleh NB, Mohler PJ, Yu J, et al. 2013. A novel core-shell microcapsule for encapsulation and 3D culture of embryonic stem cells. J Mater Chem B. 2013(7):1002–1009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.